Expression of Hepatic Drug-Metabolizing Cytochrome P450 Enzymes and Their Intercorrelations: A Meta-Analysis

被引:169
作者
Achour, Brahim [1 ]
Barber, Jill [1 ]
Rostami-Hodjegan, Amin [1 ,2 ]
机构
[1] Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England
[2] Certara Co, Simcyp Ltd, Sheffield, S Yorkshire, England
关键词
HUMAN LIVER-MICROSOMES; CONSTITUTIVE ANDROSTANE RECEPTOR; IN-VITRO; N-DEMETHYLATION; UDP-GLUCURONOSYLTRANSFERASES; INTERINDIVIDUAL VARIABILITY; ABSOLUTE QUANTIFICATION; XENOBIOTIC METABOLISM; CATALYTIC-ACTIVITY; CYP3A4; EXPRESSION;
D O I
10.1124/dmd.114.058834
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 is a family of enzymes that catalyze reactions involved in the metabolism of drugs and other xenobiotics. These enzymes are therefore important in pharmacologic and toxicologic studies, and information on their abundances is of value in the process of scaling in vitro data to in vivo metabolic parameters. A meta-analysis was applied to data on the abundance of human hepatic cytochrome P450 enzymes in Caucasian adult livers (50 studies). Despite variations in the methods used to measure the abundance of enzymes, agreement between the studies in 26 different laboratories was generally good. Nonetheless, some heterogeneity was detected (Higgins and Thompson heterogeneity test). More importantly, large interindividual variability was observed in the collated data. Positive correlations between the expression levels of some cytochrome P450 enzymes were found in the abundance data, including the following pairs: CYP3A4/CYP3A5* 1/*3 (Rs = 0.70, P < 0.0001, n = 52), CYP3A4/CYP2C8 (Rs = 0.68, P < 0.0001, n = 134), CYP3A4/CYP2C9 (Rs = 0.55, P < 0.0001, n = 71), and CYP2C8/CYP2C9 (Rs = 0.55, P < 0.0001, n = 99). These correlations can be used to demonstrate common genetic transcriptional mechanisms.
引用
收藏
页码:1349 / 1356
页数:8
相关论文
共 77 条
[1]   Simultaneous Quantification of the Abundance of Several Cytochrome P450 and Uridine 5′-Diphospho-Glucuronosyltransferase Enzymes in Human Liver Microsomes Using Multiplexed Targeted Proteomics [J].
Achour, Brahim ;
Russell, Matthew R. ;
Barber, Jill ;
Rostami-Hodjegan, Amin .
DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) :500-510
[2]  
Al Omari A., 2007, J PHARM PRACT, V20, P206, DOI DOI 10.1177/0897190007304821
[3]  
[Anonymous], BIOPHARM DR IN PRESS
[4]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[5]   Determination of a Quantitative Relationship between Hepatic CYP3A5*1/*3 and CYP3A4 Expression for Use in the Prediction of Metabolic Clearance in Virtual Populations [J].
Barter, Z. E. ;
Perrett, H. F. ;
Yeo, K. Rowland ;
Allorge, D. ;
Lennard, M. S. ;
Rostami-Hodjegan, A. .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2010, 31 (8-9) :516-532
[6]   Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling [J].
Barter, Z. E. ;
Chowdry, J. E. ;
Harlow, J. R. ;
Snawder, J. E. ;
Lipscomb, J. C. ;
Rostami-Hodjegan, A. .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (12) :2405-2409
[7]   Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver [J].
Barter, Zoe E. ;
Bayliss, Martin K. ;
Beaune, Philip H. ;
Boobis, Alan R. ;
Carlile, David J. ;
Edwards, Robert J. ;
Houston, J. Brian ;
Lake, Brian G. ;
Lipscomb, John C. ;
Pelkonen, Olavi R. ;
Tucker, Geoffrey T. ;
Rostami-Hodjegan, Amin .
CURRENT DRUG METABOLISM, 2007, 8 (01) :33-45
[8]   THE COMBINATION OF ESTIMATES FROM DIFFERENT EXPERIMENTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (01) :101-129
[9]  
Code EL, 1997, DRUG METAB DISPOS, V25, P985
[10]   Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes [J].
Dennison, Jennifer B. ;
Jones, David R. ;
Renbarger, Jamie L. ;
Hall, Stephen D. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02) :553-563